Patterns of antibiotics sensitivity in culture positive cases of urinary tract infections in children.


  • Hira Hameed IMDC, Islamabad.
  • Wajeeha Amber Karachi Institute of Medical Sciences, CMH, Karachi.
  • Aummara Rafique IMDC, Islamabad.
  • Sohail Aslam IMDC, Islamabad.
  • Imran Mahmood Khan Fazaia Medical College, Islamabad.
  • Rubina Zulfiqar IMDC, Islamabad.



Urinary Tract Infection, Antibiotic Sensitivity, Uropathogens, Narrow Spectrum Antibiotics


Objective: To determine the effective narrow spectrum antibiotics for treatment of UTI in children in order to control the rapidly increasing antibiotic resistance to broad spectrum antibiotics. Study Design: Prospective Clinical study. Setting: Department of Pediatric, Akbar Niazi Teaching Hospital, Bhara Kahu-Pakistan. Period: January 2021 to December 2021. Material & Methods: 361 children with clinical suspicion of UTI Urine samples were collected. Antimicrobial sensitivity test was applied on Samples on which bacterial growth was identified using Clinical Laboratory Standards Institute (CLSI) guidelines. The data was analyzed using SPSS version 25. Results: Total 361 patients were enrolled in the study according to inclusion criteria, out of which, 30 (8.3%) were infants (<1 years old), 178 (49.3%) were aged 1 to 5 years and 153 (42.4%) were aged from 5 to 12 years of age. Out of 361 patients, 125 (34.6%) patients were males and 236 (65.4%) were females. Out of 124 patients, whose urine culture was positive, most common pathogen was E. coli that was observed in 92 (25.5%) cases, followed by Klebsialla in 9 (2.5%) and enterococcus in 9 (2.5%) patients, Pseudomonas in 5 (1.4%), Proteus in 4 (1.1%), Mirabilis in 4 (1.1%), Acinobacter in 2 (0.6%), and enterobacter in 2 (0.6%) cases. Spectrum of sensitivity of 17 drugs was studied. The most sensitive drug was Imipenem, (29.9%), followed by Nitrofurantoin, Fosfomycin (25.8%), Amikacin (24.1%), Piperacilin / Tazobactam (22.7%). Conclusion: Thus E. coli was the most common pathogen and the most sensitive drug was Imipenem, followed by Nitrofurantoin, Fosfomycin, Amikacin, and Piperacilin / Tazobactam.

Author Biographies

Hira Hameed, IMDC, Islamabad.

FCPS, Assistant Professor (Pediatric Medicine), 

Wajeeha Amber, Karachi Institute of Medical Sciences, CMH, Karachi.

FCPS, Assistant Professor (Pediatric Medicine), 

Aummara Rafique, IMDC, Islamabad.

FCPS, Senior Registrar Pediatric Medicine, 

Sohail Aslam, IMDC, Islamabad.

FCPS, Associate Professor Pediatric Medicine, 

Imran Mahmood Khan, Fazaia Medical College, Islamabad.

FCPS, Associate Professor Pediatric Medicine, 

Rubina Zulfiqar, IMDC, Islamabad.

DCH, MCPS, FCPS, Professor & Head Pediatric Medicine,